Liu; David Y.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Liu; David Y..The latest application filed is for "conjugated hepcidin mimetics".
Company Profile
1.20.27
- Liu; David Y. - Milpitas CA
- Liu; David Y. - Palo Alto CA
- Liu; David Y. - San Francisco CA
Patent Activity
| Patent | Date |
|---|---|
| Conjugated Hepcidin Mimetics App 20210061872 - Liu; David Y. ; et al. | 2021-03-04 |
| Compounds and methods for treatment of cancer Grant 8,530,404 - Seeley , et al. September 10, 2 | 2013-09-10 |
| Diabetic nephropathy therapies Grant 8,314,059 - Flyvbjerg , et al. November 20, 2 | 2012-11-20 |
| Vascular Disease Therapies App 20120039882 - Langsetmo Parobok; Ingrid ; et al. | 2012-02-16 |
| Methods of treatment of cardiovascular disease using anti-CTGF agents Grant 8,088,381 - Langsetmo Parobok , et al. January 3, 2 | 2012-01-03 |
| Compounds and methods for treatment of cancer-related anemia App 20110015223 - Seeley; Todd W. ; et al. | 2011-01-20 |
| Diabetic nephropathy therapies App 20100291098 - Flyvbjerg; Allan ; et al. | 2010-11-18 |
| Compounds and methods for treatment of chemotherapy-induced anemia App 20100204269 - Seeley; Todd W. ; et al. | 2010-08-12 |
| Compounds and methods for treatment of chemotherapy-induced anemia Grant 7,713,986 - Seeley , et al. May 11, 2 | 2010-05-11 |
| Connective Tissue Growth Factor Signaling App 20080254487 - Klaus; Stephen J. ; et al. | 2008-10-16 |
| Methods Of Promoting Osteogenesis App 20080108658 - Protter; Andrew A. ; et al. | 2008-05-08 |
| Pyrido-pyrimidine compounds as medicaments Grant 7,345,045 - Chakravarty , et al. March 18, 2 | 2008-03-18 |
| Compounds and methods for treatment of chemotherapy-induced anemia App 20070292433 - Seeley; Todd W. ; et al. | 2007-12-20 |
| Compounds and methods for treatment of cancer-related anemia App 20070293575 - Seeley; Todd W. ; et al. | 2007-12-20 |
| Methods of promoting osteogenesis Grant 7,268,139 - Protter , et al. September 11, 2 | 2007-09-11 |
| Compounds and methods to treat cardiac failure and other disorders Grant 7,189,739 - Mavunkel , et al. March 13, 2 | 2007-03-13 |
| Compounds and methods for treatment of cancer App 20070004627 - Seeley; Todd W. ; et al. | 2007-01-04 |
| Vascular disease therapies App 20060281668 - Parobok; Ingrid Langsetmo ; et al. | 2006-12-14 |
| Cardiovascular disease therapies App 20060281667 - Langsetmo Parobok; Ingrid ; et al. | 2006-12-14 |
| Cytoprotection through the use of hif hydroxylase inhibitors App 20060251638 - Guenzler-Pukall; Volkmar ; et al. | 2006-11-09 |
| Treatment of malignant gliomas with TGF-beta inhibitors App 20050245508 - Weller, Michael ; et al. | 2005-11-03 |
| Quinazoline derivatives as medicaments App 20050220784 - Chakravarty, Sarvajit ; et al. | 2005-10-06 |
| Diabetic nephropathy therapies App 20050214294 - Flyvbjerg, Allan ; et al. | 2005-09-29 |
| Quinazoline derivatives as medicaments App 20050171123 - Chakravarty, Sarvajit ; et al. | 2005-08-04 |
| Quinazoline derivatives as medicaments Grant 6,903,096 - Chakravarty , et al. June 7, 2 | 2005-06-07 |
| Methods of promoting osteogenesis App 20040162289 - Protter, Andrew A. ; et al. | 2004-08-19 |
| Methods for improvement of lung function using TGF-beta inhibitors App 20040146509 - Li, Zhihe ; et al. | 2004-07-29 |
| Use of TGF-beta inhibitors to counteract pathologic changes in the level or function of steroid/thyroid receptors App 20040138188 - Higgins, Linda S. ; et al. | 2004-07-15 |
| Method for counteracting a pathologic change in the beta-adrenergic pathway App 20040127575 - Ying, Feng ; et al. | 2004-07-01 |
| Treatment of fibroproliferative disorders using TGF-beta inhibitors App 20040038856 - Chakravarty, Sarvajit ; et al. | 2004-02-26 |
| Method to treat cystic fibrosis App 20040009990 - Higgins, Linda S. ; et al. | 2004-01-15 |
| Compounds and methods to treat cardiac failure and other disorders Grant 6,589,954 - Mavunkel , et al. July 8, 2 | 2003-07-08 |
| Compounds and methods to treat cardiac failure and other disorders App 20030073699 - Mavunkel, Babu J. ; et al. | 2003-04-17 |
| Quinazoline derivatives as medicaments App 20030069248 - Chakravarty, Sarvajit ; et al. | 2003-04-10 |
| Inhibitors of p38-a kinase Grant 6,541,477 - Goehring , et al. April 1, 2 | 2003-04-01 |
| Quinazoline derivatives as medicaments Grant 6,476,031 - Chakravarty , et al. November 5, 2 | 2002-11-05 |
| Quinazoline derivatives as medicaments App 20020161010 - Chakravarty, Sarvajit ; et al. | 2002-10-31 |
| Compounds and methods to treat cardiac failure and other disorders Grant 6,448,257 - Mavunkel , et al. September 10, 2 | 2002-09-10 |
| Inhibitors of p38-a kinase App 20020115671 - Goehring, R. Richard ; et al. | 2002-08-22 |
| Inhibitors of p38-.alpha.kinase Grant 6,410,540 - Goehring , et al. June 25, 2 | 2002-06-25 |
| Compounds and methods to treat cardiac failure and other disorders Grant 6,340,685 - Mavunkel , et al. January 22, 2 | 2002-01-22 |
| Quinazoline derivatives as medicaments Grant 6,277,989 - Chakravarty , et al. August 21, 2 | 2001-08-21 |
| Quinazoline derivatives as inhibitors of P-38 .alpha. Grant 6,184,226 - Chakravarty , et al. February 6, 2 | 2001-02-06 |
| Compounds and methods to treat cardiac failure and other disorders Grant 6,130,235 - Mavunkel , et al. October 10, 2 | 2000-10-10 |
| Peptide medicaments for the treatment of disease Grant 5,340,800 - Liu , et al. August 23, 1 | 1994-08-23 |
| Method for inhibing adhesion of white blood cells to endothelial cells Grant 5,166,133 - Houston , et al. November 24, 1 | 1992-11-24 |
Company Registrations
| SEC | 0001675881 | Liu David Y |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 